eXoZymes, Inc.
EXOZ
$10.76
-$0.095-0.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 52.33% | -18.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.06% | 21.31% | |||
| Operating Income | -23.06% | -21.31% | |||
| Income Before Tax | -10.97% | -21.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.84% | -21.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.84% | -21.75% | |||
| EBIT | -23.06% | -21.31% | |||
| EBITDA | -24.17% | -22.40% | |||
| EPS Basic | 7.59% | -21.74% | |||
| Normalized Basic EPS | 7.49% | -21.94% | |||
| EPS Diluted | 7.59% | -21.74% | |||
| Normalized Diluted EPS | 7.49% | -21.94% | |||
| Average Basic Shares Outstanding | 19.95% | 0.02% | |||
| Average Diluted Shares Outstanding | 19.95% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||